Congenital Ichthyosis
6
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
13 treatments under study, led by Symptomatic Therapy
Research Leaders
6 sponsors active, led by Maastricht University Medical Center
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (6)
A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis
Quality of Life in Middle-aged and Older Patients With Congenital Ichthyosis
Efficacy of Injectable Gentamicin in Hereditary Ichthyosis
Exploring Patient Reported Outcomes in Inherited Ichthyosis
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children
Research Network
Common Treatments
- Symptomatic Therapy1
- Dupilumab1
- Vehicle1
- Vehicle For Pat001 011
- Gentamicin1
Active Sponsors
- Maastricht University Medical Center2
- University Hospital, Toulouse1
- Centre Hospitalier Universitaire De Toulouse1
- LEO Pharma1
- Patagonia Pharmaceuticals, LLC1
Top Investigators
Maastricht UMC
Maastricht UMC
Sponsor GmbH
University Hospital, Toulouse
Related Conditions
- Ichthyosis1